TransUnion carries a market capitalization of 12.94B, placing it among publicly traded companies globally. Its enterprise value stands at 18.80B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 12.94B |
| Enterprise Value | 18.80B |
TransUnion currently has 191.60M shares outstanding.
| Shares Outstanding | 191.60M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
TransUnion trades at a trailing price-to-earnings ratio of 18.88. The price-to-sales ratio is 2.85, and the price-to-book ratio stands at 2.85.
| PE Ratio | 18.88 |
| PS Ratio | 2.85 |
| PB Ratio | 2.85 |
| P/TBV Ratio | -3.08 |
| P/FCF Ratio | 12.76 |
| P/OCF Ratio | 12.64 |
On an enterprise value basis, TransUnion trades at an EV/EBITDA multiple of 12.31 and an EV/FCF ratio of 14.37. The EV/Sales ratio of 3.84 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 20.41 provides insight into valuation relative to core operating earnings.
| EV / Sales | 3.84 |
| EV / EBITDA | 12.31 |
| EV / EBIT | 20.41 |
| EV / FCF | 14.37 |
TransUnion maintains a current ratio of 1.90, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 113.21, indicating elevated leverage, while an interest coverage ratio of 6.06 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.90 |
| Quick Ratio | 1.65 |
| Debt / Equity | 113.21 |
| Debt / EBITDA | 3.71 |
| Interest Coverage | 6.06 |
TransUnion posts a return on equity of 15.77 and a return on invested capital of 7.35.
| Return on Equity (ROE) | 15.77 |
| Return on Assets (ROA) | 6.34 |
| Return on Invested Capital (ROIC) | 7.35 |
| Return on Capital Employed (ROCE) | 9.08 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, TransUnion has paid 170.10M in income taxes, reflecting an effective tax rate of 18.45.
| Income Tax | 170.10M |
| Effective Tax Rate | 18.45 |
TransUnion's stock has declined approximately -19.89088% over the past 52 weeks. The 50-day moving average sits at 79.31, while the 200-day moving average is 76.01.
| Beta (5Y) | N/A |
| 52-Week Price Change | -19.89088% |
| 50-Day Moving Average | 79.31 |
| 200-Day Moving Average | 76.01 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, TransUnion generated 4.90B in revenue and converted that into 738.30M in net income, yielding earnings per share of 3.85. EBITDA reached 1.53B, while operating income came in at 920.90M.
| Revenue | 4.90B |
| Gross Profit | 2.88B |
| Operating Income | 920.90M |
| Pretax Income | 922.00M |
| Net Income | 738.30M |
| EBITDA | 1.53B |
| EBIT | 920.90M |
| Earnings Per Share (EPS) | 3.85 |
TransUnion holds 839.50M in cash and equivalents against 5.66B in total debt, resulting in a net debt position of 4.75B. Total book value stands at 4.84B, with working capital of 1.03B providing operational flexibility.
| Cash & Cash Equivalents | 839.50M |
| Total Debt | 5.66B |
| Net Debt | 4.75B |
| Equity (Book Value) | 4.84B |
| Book Value Per Share | 25.28 |
| Working Capital | 1.03B |
TransUnion produced 1.10B in operating cash flow over the past twelve months.
| Operating Cash Flow | 1.10B |
| Capital Expenditures | N/A |
| Free Cash Flow | 1.10B |
| FCF Per Share | 5.71 |
TransUnion operates with a gross margin of 58.73, reflecting its pricing power and cost economics. The operating margin of 18.81 and net profit margin of 15.08 provide insight into operational efficiency.
| Gross Margin | 58.73 |
| Operating Margin | 18.81 |
| Pretax Margin | 18.83 |
| Profit Margin | 15.08 |
| EBITDA Margin | 31.19 |
The company's payout ratio of 12.39 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.49 |
| Dividend Yield | N/A |
| Payout Ratio | 12.39 |
| Shareholder Yield | 1.07 |
| FCF Yield | 7.84 |
TransUnion posts an Altman Z-Score of 5.94, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.94 |